טוען...
Cost Burden of Cardiovascular Hospitalization and Mortality in ATHENA‐Like Patients With Atrial Fibrillation/Atrial Flutter in the United States
BACKGROUND: The ATHENA trial (A placebo‐controlled, double‐blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter) demonstrated that dronedarone reduce...
שמור ב:
| הוצא לאור ב: | Clin Cardiol |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wiley Periodicals, Inc.
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6652891/ https://ncbi.nlm.nih.gov/pubmed/20513065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20759 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|